The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...
| Autors principals: | , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Taylor & Francis Group
2024-12-01
|
| Col·lecció: | Human Vaccines & Immunotherapeutics |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969 |